Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Background Critical examination of the quality and validity of available allergic rhinitis (AR)
literature is necessary to improve understanding and to appropriately translate this …

The availability of allergen molecules ('components') from several protein families has
advanced our understanding of immunoglobulin E (IgE)‐mediated responses and enabled …

Progressive knowledge of allergenic structures resulted in a broad availability of allergenic
molecules for diagnosis. Component‐resolved diagnosis allowed a better understanding of …

The extensive use of allergen molecules in birth cohort studies revealed that atopic
sensitization is a sequential IgE response to distinct non–cross-reacting molecules from the …

Allergen immunotherapy (AIT) is the only disease‐modifying treatment option for patients
with IgE‐mediated inhalant allergies. Though used in clinical practice for more than 100 …

Allergen-specific immunotherapy (AIT) is currently recognized as a clinically effective
treatment for allergic diseases, with a unique disease-modifying effect. AIT was introduced in …

Allergen Immunotherapy (AIT) was introduced in clinical practice on an empirical basis more
than 100 years ago. Since the first attempts, AIT was administered subcutaneously. Indeed …

Precision allergy molecular diagnostic applications (PAMD@) is increasingly entering
routine care. Currently, more than 130 allergenic molecules from more than 50 allergy …